Citicoline Stroke Study "Citicoline 001"

Completed

Phase 3 Results

Summary of Purpose

To evaluate the effectiveness of citicoline in acute stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 October 2000.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Interneuron Pharmaceuticals, Lexington, MA

Trial Design

Randomized (3 doses of citicoline to 1 placebo), vehicle-controlled, double-blind trial involving 259 patients at 21 centers.

Contacts

Not available